Fig. 2From: Treatment patterns and characteristics of patients with migraine: results from a retrospective database study in JapanTreatment patterns in patients in the migraine cohort from 2018 to 2022. a Trend of acute treatment over years. b Trend of preventive treatment over years. Number of patients: 2018-2022 (n=165,339), 2018 (n=35,614), 2019 (n=44,253), 2020 (n=47,719), 2021 (n=61,949), 2022 (n=44,307). Ca, calcium; CGRP, calcitonin gene-related peptide; mAb, monoclonal antibody; NSAID, non-steroidal anti-inflammatory drugBack to article page